|
⚲
|
| Keyboard |
| Partridge Andrew John
✚
|
|
|---|---|
| CIK # | 0001758838 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001758838] | |
| 4 | [0001758838] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Grail LLC | |
| Partridge Andrew John | |
| Turning Point Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Turning Point Therapeutics Inc TPTX
Common Stock
|
2022-02-09 | Sell | 221 | $36.30 | 8,022 |
|
Turning Point Therapeutics Inc TPTX
Stock Option (right to buy) · derivative
|
2022-02-09 | Grant | 58,600 | $0.00 | |
|
Turning Point Therapeutics Inc TPTX
Common Stock
|
2022-02-09 | Grant | 16,283 | $0.00 | |
|
Turning Point Therapeutics Inc TPTX
Common Stock
|
2021-07-14 | Sell | 1,869 | $74.90 | 139,988 |
|
Turning Point Therapeutics Inc TPTX
Stock Option (right to buy) · derivative
|
2021-02-08 | Grant | 9,733 | $0.00 | |
|
Turning Point Therapeutics Inc TPTX
Common Stock
|
2021-02-08 | Grant | 2,136 | $0.00 | |
|
Turning Point Therapeutics Inc TPTX
Common Stock
|
2020-07-13 | Grant | 21,500 | $0.00 | |
|
Turning Point Therapeutics Inc TPTX
Stock Option (right to buy) · derivative
|
2020-07-13 | Grant | 127,500 | $0.00 |